|
|
||||||||
1Department of Physiology, Medical College of Wisconsin, Milwaukee Wisconsin, and 2Department of Cellular and Integrative Physiology, Indiana University, Indianapolis, Indiana
Submitted 21 July 2006 ; accepted in final form 13 May 2007
| ABSTRACT |
|---|
|
|
|---|
ischemia; blood pressure; sodium sensitivity
Alterations in renal vascular structure and function are well-described in the setting of renal I/R injury. For example, endothelial injury has been described as lost barrier function and increased adhesion to inflammatory cells (42, 43, 46). In addition, early reductions in blood flow that occur within minutes of reperfusion can be ameliorated by supplementation with transplanted endothelial cells (3, 46). We have reported that there is a loss of peritubular capillaries and a decrease in oxygen delivery in the kidney following the initial recovery response from ARF. These observations on long-term blood vessel density emanated from our studies (5, 8), and those of other investigators (10, 15, 17, 18, 34, 35), that renal function does not recover completely following I/R. For example, postischemic rats develop a urinary concentrating defect and develop secondary chronic and progressive renal disease characterized by progressive proteinuria and interstitial fibrosis.
These observations, made in animal models, may have relevance to clinical studies that have reported an incomplete recovery following ARF and a secondary decline in renal function (11, 14, 23). The development of chronic and progressive renal dysfunction following severe ARF has been reported by several investigators (5, 11, 14, 23). As such, several clinical studies report that the complete normalization of renal function may never be achieved, and other studies report that a small percentage of patients will show a progressive loss of renal function over time (5, 11, 14, 23). This may be particularly prominent in the pediatric population; in a recent study, >50% of pediatric patients showed indications of progressive renal disease and hypertension within 35 years of the initial episode (4). As a corollary to ARF, delayed graft function following renal transplantation is associated with an increased risk for renal nephropathy and hypertension (29, 31, 32). These studies suggest an association of acute kidney injury and the development of chronic renal disease. However, the nature of altered function is not well explored. One hypothesis is that reductions in peritubular capillary density may predispose chronic renal failure, perhaps due to hypoxia. Interestingly, there are a number of models characterized by renal interstitial damage that also show reductions in peritubular capillary density; these include those induced by cyclosporine, radiation, aging, and catecholamine infusion (20, 24). Moreover, these models have also been characterized by the predisposition of sodium-dependent hypertension. Therefore, because recovery from ARF has features in common with many of these models, we sought to determine if postischemic animals would develop sodium-dependent hypertension.
| METHODS |
|---|
|
|
|---|
Male Sprague-Dawley rats weighing
250 g were housed in pairs in standard shoebox cages on a 12/12-h light/dark cycle. Animals were given standard laboratory rat chow (AIN76A; Dyets, Bethlehem, PA) with a defined 0.4% or 4.0% salt content, as described below; food and water was available ad libitum.
Protocol I was designed to determine the effects of I/R injury on the development of sodium-sensitive hypertension. In these studies, rats were acclimated to 0.4% salt diet. Before ischemia, rats were instrumented with chronic blood pressure transducers; rats were anesthetized with ketamine HCl (60 mg/kg ip), xylazine (6 mg/kg ip), and acepromazine maleate (0.9 mg/kg ip). The catheter tip of the telemetric blood pressure transducer (TA11PA-C40; Data Science) was implanted into the right femoral artery, and the body of the pressure transducer was implanted subcutaneously. Rats were allowed to recover for 14 days, during which baseline blood pressure measurements were taken at 7 days before ARF induction. To induce ARF, rats were anesthetized with ketamine (100 mg/kg ip) and pentobarbital sodium (25 mg/kg ip) and were placed on a heated surgical table. A midline incision was made. Blood supply to the kidneys was interrupted by applying microvascular clamps on the renal pedicles of both kidneys. The clamps were then released, and reperfusion was visualized. Additional rats were subjected to sham surgery where the kidneys were exposed but not touched.
All animals were allowed to recover for 35 days (i.e., 5 wk after I/R or sham surgery) on a 0.4% salt diet and were then allowed to recover for an additional 28 days (total of 63 days after surgery) on either low- or high-sodium diet. One group of postischemic animals was switched at day 35 to a diet containing a high sodium content (4.0% NaCl; Dyets) for an additional 28 days; this group is referred to as I/R L-H, indicating their switch from low-sodium to high-sodium diet at day 35 (n = 7). As a control for the effects of sodium, another group of postischemic animals was maintained on 0.4% salt diet for the entire study; this group is referred to as I/R L-L, indicating that they were maintained on 0.4% salt diet after day 35 (n = 3). In the sham-operated control group, rats were switched to 4.0% salt chow at day 35 after surgery, and this group is referred to as sham L-H (n = 7). Finally, to determine the effect of reduced renal mass, some rats were subjected to right unilateral nephrectomy and sham surgery. This group was also switched to a 4.0% salt diet at day 35 and is referred to as UNx-sham L-H (n = 3). Blood pressures were measured via telemetry as described below. Animals were killed at day 63 after surgery, and kidneys were obtained for histological analysis.
Protocol II was designed similarly to protocol I and allowed for conscious creatinine measurements and analysis of plasma renin levels. Two groups of rats were subjected to sham surgery and were maintained on 0.4% salt diet (sham L-L; n = 11) for the entirety of the study or switched to 4.0% salt diet on days 3563 (sham L-H; n = 12). In addition, two groups of rats subjected to bilateral I/R were also maintained on 0.4% salt diet (I/R L-L; n = 11) or were switched to a 4.0% salt diet at day 35 (I/R L-H; n = 10). At 49 days (i.e., 7 wk after ischemia or sham surgery), rats were anesthetized with ketamine HCl (60 mg/kg ip), xylazine (6 mg/kg ip), and acepromazine maleate (0.9 mg/kg ip). Polyvinyl catheters were implanted in the femoral artery, tunneled subcutaneously, and exteriorized at the scapula. The catheters were placed inside a spring that was secured onto the rat. After recovery, rats were housed in individual stainless-steel cages. The rats were allowed to recover for an additional 1 wk after surgery. Beginning at day 56 (i.e., wk 8 after ischemia and sham surgery), blood pressure was measured in conscious rats via femoral catheter from 0900 to 1200. After blood pressure measurements, plasma samples were obtained in these conscious rats through the arterial catheter for measurement of plasma creatinine, sodium, and renin activity. Urine was collected overnight for measurement of urinary sodium, creatinine, and albumin excretion rates.
Protocol III was similar to protocol I but was designed to more thoroughly assess the effects of sodium on renal morphology and the development of proteinuria without the use of blood pressure measurements. Urine was collected for 24 h in metabolic cages at days 1, 28, 35, 42, 56, and 63 after surgery. Animals were killed at day 63 after surgery after the last urine collection, and tissues were processed for histological analysis (see below).
Protocol IV was designed to determine the effects of acclimation of animals to 4.0% salt diet before the initiation of I/R injury on the extent of renal damage and the development of secondary complications. Rats were acclimated on 4.0% salt for a minimum of 7 days and were subjected to I/R surgery and reperfusion. These animals were maintained on 4.0% salt diet with urine collections occurring weekly. At 49 days (i.e., 7 wk post ischemia), telemetric blood pressure transducers were implanted into the right femoral artery as in protocol I for acquisition of blood pressure between days 56 and 63. Postischemic animals in this group did not tolerate this procedure well (see RESULTS).
Measurement of renal function. For measurement of serum creatinine, tail blood samples (0.5 ml) were collected into heparinized tubes and plasma was obtained by centrifugation. Serum and urine creatinine were determined by using standard assays (Sigma creatinine kit 555A). Urine volume from metabolic cages was determined gravimetrically. Urine albumin content was measured by using the albumin blue 580 fluorescence method (Fluka), as previously described (8). Plasma renin activity was measured in blood samples from conscious untouched animals instrumented as described in protocol II by using a modification of the method described by Sealey and Laragh (40).
Measurement of blood pressure. For protocols I and IV, blood pressure was measured telemetrically from 0900 to 1200 by using DSI Dataquest ART acquisition software. Blood pressure in rats was measured weekly during recovery on low-sodium diet through day 35. After the switch to high-sodium diet on day 35, blood pressure was measured twice weekly until day 63 after ischemia. Mean arterial blood pressures were established for each animal at each collection time by averaging blood pressure values over the 3-h collection period. For protocol I, Baseline blood pressures for each animal were established by averaging blood pressure values obtained at days 14, 21, and 28, which correspond to the three blood pressure measurements just before changing dietary sodium level. Blood pressure is expressed as a change in baseline measurements to account for differences in baseline blood pressure between rats.
For protocol II, blood pressure was measured through the exteriorized catheters and was measured between 0900 and 1200 on days 5660. Measurements were made online by using a solid-state pressure transducer (Argon Medical Technologies, Athens, TX). Signals were amplified and acquired online by custom-designed data-acquisition software (Department of Physiology, Medical College of Wisconsin); pulsatile blood pressure signals were reduced to periodic (1-min) averages of mean arterial pressure. Data are expressed as mean arterial pressure averaged over the course of the 3-h time period (28).
Assessment of interstitial cellularity. At 63 days after ischemia, rats were anesthetized with ketamine HCl (60 mg/kg), xylazine (6 mg/kg), and acepromazine maleate (0.9 mg/kg). The kidneys were quickly removed and cut longitudinally. Half of each kidney was immersed in 10% formalin and was processed for histological analysis. For morphometric measurements, tissues were combined from protocols I and III. Determination of the degree of interstitial cellularity was carried out on photomicrographs of hematoxylin and eosin-stained kidney sections as previously described (41). A minimum of five representative micrographs were taken from each zone of the kidney of each animal. Computer-aided image analysis (MetaMorph) was used to apply an arbitrary array of points over the photomicrographs, and points were counted that lay over structures that corresponded to acellular, tubular lumen, glomerular, tubular epithelium, or interstitial cell types. Data are presented as the average number of points overlying each structure.
Immunohistochemistry. Localization of ED-1 was performed on 3-µm formalin-fixed paraffin sections. Sections were stained by using a robotic Dako autostainer (S3400). Following deparaffinization and rehydration, tissue was prepared as follows: 1) antigen retrieval was performed by incubating in proteinase K; 2) endogenous peroxidase activity was blocked by incubation in 3% H2O2; 3) endogenous biotin was blocked with sequential incubations with avidin and biotin (avidin-biotin blocking kit; Zymed); and 4) nonspecific sites were blocked by incubation in 0.01 M PBS containing 0.3% Triton X-100, 10% goat serum, and 0.3% BSA. ED-1 antibody was obtained from Serotec (MCA341R; 1 µg/ml) and localized with a Vectastain ABC kit (Vector Laboratory) using diaminobenzidine tetrahydrochloride as a substrate.
Localization of fibroblasts and myofibroblasts was carried out by staining with antibodies to S100A4 and smooth muscle actin. S100A4 staining was carried out by using a primary antibody obtained from Dako as described previously (9) and by using AEC as a substrate; colocalization with
-smooth muscle actin was performed by using an antibody from Zymed as described previously (7) and by using alkaline phosphatase/NTB as a method for detection.
Assessment of glomerular damage. Sections of fixed, paraffin-embedded kidneys were stained with Masson's trichrome and were visualized by using a Nikon Eclipse E400 microscope. Glomeruli (3040 per rat) were scored by using a semiquantitative index developed by Raij et al. (37) in which a glomerular score of 0 is considered normal and in which a score of 4 is considered most severely damaged, indicated by occlusion of capillaries with matrix.
| RESULTS |
|---|
|
|
|---|
|
|
We confirmed the effect of 4.0% salt and I/R injury on mean arterial pressure in second series of studies (protocol II). In these studies, blood pressure of postischemic rats switched to 4.0% salt diet measured between days 56 and 60 was 142 ± 7 mmHg and was significantly greater than values measured in sham-operated controls placed on 4.0% salt (125 ± 1 mmHg). This value was not different from values obtained from either sham-operated or postischemic animals maintained on 0.4% salt diets (Table 2).
|
Animals from protocols I and III were used to obtain frequent urine samples to determine the onset of albuminuria following I/R injury. In agreement with our previous studies, albumin excretion was modest in postischemic animals maintained on a 0.4% salt chow for the entire 63 days of recovery (6, 8). In contrast, when postischemic rats were switched to a 4.0% salt diet, albuminuria developed rapidly. This was not observed in sham-operated controls on a 4.0% salt diet (Fig. 2). Similar results were obtained when albumin excretion was determined in protocol II at day 56 after ischemia (28 mg/day for ARF L-H vs. 3 mg/day for ARF L-L; P < 0.05 by Student's t-test).
|
|
-smooth muscle actin (blue staining) were typically observed in vascular bundles and only mildly in the interstitial space in postischemic animals maintained on low-sodium diet, whereas interstitial smooth muscle actin staining was more prominent when postischemic animals were switched to the 4.0% salt diet (Fig. 4, C vs. D).
|
|
100 mg/day, which is substantially higher than levels measured in rats changed to 4.0% salt at 5 wk (compare with Fig. 2). These observations suggest that acclimation to 4.0% salt before initiation of I/R does not interfere with early or progressive manifestations of renal I/R. These data also highlight the heterogeneity of the secondary progression of injury following I/R. Indeed, initiating serum creatinine values measured 24 h following I/R between rats that survived and those that perished at the time of implantation surgery were not different (Fig. 6, top), although both albuminuria and serum creatinine values at later time points were different in these groups. The reason for this heterogeneity is unclear.
|
| DISCUSSION |
|---|
|
|
|---|
Similarly, studies using other models have shown that transient or subtle injuries may predispose the kidney to future complications. Johnson and colleagues (21) have shown that subtle renal injury induced by ANG II predisposes the development of sodium-dependent hypertension. In this model, ANG II (435 ng·kg1·min1) was infused with subcutaneous osmotic minipumps for 2 wk, resulting in decreased peritubular capillaries and tubulointerstitial damage (1, 24). Similarly, treating rats with cyclosporine for 4 wk (8 mg·kg1·day1) resulted in tubulointerstitial damage. In both studies, these treatments resulted in the development of sodium-dependent hypertension, and the tubulointerstitial damage correlated with the increase in blood pressure. The alteration in blood pressure may be associated with a decrease in medullary blood flow as suggested by Cowley and colleagues (16). In view of our previous studies on the effects of ARF on capillary density, these observations led us to hypothesize that post-ARF animals would develop sodium-dependent hypertension.
In this study, we examined the influence of sodium on long-term postischemic function and morphology in rats. The protocols used allowed animals to recover on 0.4% salt diet, enabling recovery without overt evidence of renal disease. However, because animals on 0.4% salt have higher plasma renin activity than animals on 4.0% salt, additional studies were carried out to demonstrate that the reported effects were not due to sensitization by ANG II at the time of renal injury. The data presented in this report are consistent with our previous observation (6, 8) that ARF, in and of itself, is not sufficient to increase blood pressure. Nevertheless, our data clearly demonstrate that, when challenged with a high-sodium diet, postischemic animals do develop increased blood pressure over time. The mechanism by which blood pressure is increased in postischemic animals following I/R is not yet known; however, these data are consistent with the suggestion that I/R injury compromises the normal sodium-handling capabilities of the kidney even after the apparent recovery from the initiating insult.
With regard to possible causes of sodium-dependent hypertension following recovery from I/R injury, it is possible that incomplete tubular repair may lead to a dropout of functioning nephrons, resulting in hyperfiltration and susceptibility to sodium-dependent hypertension (13, 35). Although reduction of functioning nephrons by unilateral nephrectomy did not result in an elevation in blood pressure in animals changed to a high-sodium diet, the potential that hyperfiltration is present in postischemic animals following bilateral I/R has not been addressed, and its potential role in sodium sensitivity remains an issue to be clarified. Importantly, we must point out that although creatinine clearance values were not different in postischemic vs. sham-operated animals, we did not carry out formalized analysis of glomerular filtration rate (GFR) at recovery by inulin clearance in the current series of studies. A more formal evaluation of GFR and renal hemodynamics in the recovery state will be required to gain a clear understanding of the mechanism of altered Na sensitivity in this model.
Alternatively, Johnson and Schereiner (22) suggested that alterations in the tubulointerstitium (including peritubular capillary loss, fibrosis, and hypoxia, features that are all present in this model) lead to sodium retention. These features are consistent with our previous characterization of I/R-induced injury. We have suggested that the loss of peritubular capillaries in response to I/R compromises the oxygen delivery to renal parenchyma and may contribute to secondary damage in the kidney (7). Chronic renal hypoxia is been associated with increased glomerular hypertrophy, arteriolar thickening, tubulointerstitial inflammation, and fibrosis (28). It has been suggested that alterations in the renal interstitium may affect sodium by altering normal sodium-handling mechanisms such as the tubuloglomerular feedback mechanism or by affecting interstitial pressures that regulate sodium diffusion across tubular epithelia (22).
Such effects may be mediated by alterations in intrinsic renal vasoactive factors. It is also possible that ARF contributes to an imbalance of vasoactive factors, resulting in sodium-sensitive hypertension. For example, we have previously found (9) that I/R injury results in a substantial reduction in the renal expression of kallikrein. Kallikrein stimulates the production of bradykinin- and NO-dependent vasodilatory factors. Reduction in kallikrein levels has been implicated in sodium-sensitive hypertension, blood pressure regulation, and sodium excretion (25). Infusion of subdepressor doses of kallikrein attenuates hypertension in Dahl salt-sensitive rats. In humans, administered kallikrein normalizes blood pressure in hypertensive patients (2).
Data from the current study suggest that the alterations in sodium sensitivity are not attributable to inappropriate regulation of renin, and, in a recent study (6), we also found no evidence that ARF chronically affects circulating ANG II concentration. Nevertheless, ANG II responsiveness may be increased in postischemic rats (6, 8). In the current study, we did not evaluate intrarenal ANG II, and we cannot rule out that intrarenal ANG II may participate in the sodium sensitivity described in this study.
In addition to the hypertension, sodium dramatically hastens the secondary renal damage characterized by tubulointerstitial damage and albuminuria after ischemia. The hypertrophy in postischemic rats is consistent with our previous studies. However, the addition of sodium to animals recovered from I/R had a striking effect on the degree of hypertrophy, deposition of interstitial cells, and renal scarring seen in post I/R kidneys. How sodium intake exacerbates secondary renal disease following I/R injury is not yet clear. However, it is possible that increased blood pressure in response to high-sodium diet exacerbates the injury process or conversely that it fuels proliferation of fibroblastic and inflammatory cell types that deposited in the interstitium following the initial recovery response. In the current study, transfer of animals to a 4.0% salt diet exacerbated fibrosis that was characterized by an increase in the number of in macrophages and fibroblasts. How dietary sodium would affect these pathways directly is unclear, although a number of profibrotic factors such as TGF-
may be regulated by sodium in the diet (47). We suggest that alterations of such factors in the setting of recovery from I/R results in a greater degree of tissue damage than would be manifested in the setting of elevated sodium by itself. In addition, other models of renal injury are characterized by infiltration of T cells and monocytes in the renal interstitium. The T cells produce ANG II and reactive oxygen species (36, 38, 39). By blocking the inflammatory response with mycophenolate mofetil, the leukocyte accumulation was blocked and animals did not develop sodium-sensitive hypertension.
In summary, data from this study support the view that elements of renal function are not reversible in the setting of ARF induced by I/R injury. Despite the initial recovery response of GFR and tubular regeneration, postischemic animals have a defect in their normal ability to handle sodium. One element of this is the predisposition to develop hypertension and hasten the progression of secondary renal disease when sodium intake is elevated. These results may be due to alterations in the vasculature of the kidney, as described previously (7, 8). However, the specific role of capillary dropout, interstitial cell deposition, or other elements of altered renal structure or function that may be affected chronically by I/R on sodium sensitivity have not yet been evaluated.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
in acute renal failure: receptor expression, effects on proliferation, cellularity and vascularization after recovery from injury. Am J Physiol Renal Physiol 288: F568F577, 2005.This article has been cited by other articles:
![]() |
D. A. Ayupova, M. Singh, E. C. Leonard, D. P. Basile, and B. S. Lee Expression of the RNA-stabilizing protein HuR in ischemia-reperfusion injury of rat kidney Am J Physiol Renal Physiol, July 1, 2009; 297(1): F95 - F105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anderson, J. B. Halter, W. R. Hazzard, J. Himmelfarb, F. M. Horne, G. A. Kaysen, J. W. Kusek, S. G. Nayfield, K. Schmader, Y. Tian, et al. Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1199 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, M. Theodorakis, A. Laggouranis, and K. N. Vemmos Long-Term Prognosis of Acute Kidney Injury after First Acute Stroke Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 616 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Leonard, J. L. Friedrich, and D. P. Basile VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1648 - F1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Parikh, S. G. Coca, Y. Wang, F. A. Masoudi, and H. M. Krumholz Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction Arch Intern Med, May 12, 2008; 168(9): 987 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Pechman, D. P. Basile, H. Lund, and D. L. Mattson Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1234 - R1239. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |